BWG vs EVG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 1/9, indicating weak operational and balance sheet fundamentals. Despite a current price of $8.47 and a growth-based intrinsic value estimate of $6.44, the stock trades at a premium with no verifiable safety margin. Profitability metrics are entirely absent (0.00% margins), and the dividend is unsustainable with a 104.35% payout ratio, raising concerns about future cuts. Technical trend is deeply bearish (0/100), and insider sentiment, while neutral, lacks supporting activity, further weakening confidence.
EVG presents as a deep-value play with a stable Piotroski F-Score of 6/9, trading significantly below both its Graham Number ($16.79) and Intrinsic Value ($32.45). While the fund exhibits strong profitability metrics and a highly attractive 8.20% dividend yield, it is hampered by negative revenue growth (-11%) and a completely bearish technical trend (0/100). The disconnect between the fundamental value and the market price suggests a value trap risk or a significant lag in market recognition. Overall, the stability of the balance sheet is offset by poor momentum and declining top-line growth.
Compare Another Pair
Related Comparisons
BWG vs EVG: Head-to-Head Comparison
This page compares Legg Mason BW Global Income Opportunities Fund Inc. (BWG) and Eaton Vance Short Duration Diversified Income Fund (EVG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.